Our study demonstrated that GPR43 deficiency downregulated LDLR-mediated cellular cholesterol uptake and restored podocyte autophagic flux to facilitate CE degradation, which exerted a robust protective effect by reducing cholesterol loading in podocytes in DN. This evidence concerns the gene FFAR2 and liver dysplastic nodule.